[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AT320641B - Verfahren zur Herstellung von Oxazolinen - Google Patents

Verfahren zur Herstellung von Oxazolinen

Info

Publication number
AT320641B
AT320641B AT944572A AT944572A AT320641B AT 320641 B AT320641 B AT 320641B AT 944572 A AT944572 A AT 944572A AT 944572 A AT944572 A AT 944572A AT 320641 B AT320641 B AT 320641B
Authority
AT
Austria
Prior art keywords
oxazolines
preparation
Prior art date
Application number
AT944572A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712155492 external-priority patent/DE2155492C3/de
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of AT320641B publication Critical patent/AT320641B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/12—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT944572A 1971-11-09 1972-11-07 Verfahren zur Herstellung von Oxazolinen AT320641B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712155492 DE2155492C3 (de) 1971-11-09 Verfahren zur Herstellung von 2-substituierten Bis- und Tris - A2"0"101«1«1

Publications (1)

Publication Number Publication Date
AT320641B true AT320641B (de) 1975-02-25

Family

ID=5824543

Family Applications (1)

Application Number Title Priority Date Filing Date
AT944572A AT320641B (de) 1971-11-09 1972-11-07 Verfahren zur Herstellung von Oxazolinen

Country Status (10)

Country Link
US (1) US3917631A (de)
JP (1) JPS5242795B2 (de)
AT (1) AT320641B (de)
BE (1) BE791083A (de)
CA (1) CA985287A (de)
CH (1) CH574945A5 (de)
FR (1) FR2160126A5 (de)
GB (1) GB1400796A (de)
IT (1) IT970282B (de)
NL (1) NL7214977A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066743A (en) * 1976-06-21 1978-01-03 Mallinckrodt, Inc. X-ray contrast agents
US4543414A (en) * 1978-12-05 1985-09-24 The Dow Chemical Company Liquid phase preparation of 2-substituted-2-oxazolines with cadmium salt catalysts
JPS5623545U (de) * 1979-08-01 1981-03-03
US4354029A (en) * 1981-11-30 1982-10-12 The Dow Chemical Company Preparation of 2-substituted-2-oxazolines with organic zinc salt catalysts
US4515946A (en) * 1981-12-23 1985-05-07 Hoechst-Roussel Pharmaceuticals Inc. 6,11-Dihydro-11-oxo-dibenz-[b,e]oxepin derivatives
US4576960A (en) * 1981-12-23 1986-03-18 Hoechst Roussel Pharmaceuticals Incorporated 6,11-Dihydro-11-oxo-dibenz[b,e]oxepin derivatives
EP0105944A1 (de) * 1982-10-08 1984-04-25 The Dow Chemical Company Herstellung in der flüssigen Phase von 2-substituiertes-2-oxazoline mit organischen Zinksalzen als Katalysatoren
US5414608A (en) * 1993-11-30 1995-05-09 All Line Inc. Replaceable stem structure for lamp holder
US6063885A (en) * 1998-03-10 2000-05-16 S. C. Johnson Commercial Markets, Inc. Oxazoline or oxazine methacrylate aqueous coating compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2714082A (en) * 1955-07-26 New oxazoline derivatives
US2114326A (en) * 1935-07-15 1938-04-19 Abbott Lab Aminophenyl-oxazolines

Also Published As

Publication number Publication date
NL7214977A (de) 1973-05-11
DE2155492B2 (de) 1977-04-14
FR2160126A5 (de) 1973-06-22
US3917631A (en) 1975-11-04
CA985287A (en) 1976-03-09
IT970282B (it) 1974-04-10
JPS5242795B2 (de) 1977-10-26
JPS4856668A (de) 1973-08-09
GB1400796A (en) 1975-07-23
DE2155492A1 (de) 1973-05-30
CH574945A5 (de) 1976-04-30
BE791083A (fr) 1973-05-08

Similar Documents

Publication Publication Date Title
AT322550B (de) Verfahren zur herstellung von neuen isothiocyanobenzazolen
AT318610B (de) Verfahren zur Herstellung von neuen Carboxamidotetrazol-Derivaten
AT315819B (de) Verfahren zur Herstellung von Nitrodiphenylaminverbindungen
AT309398B (de) Verfahren zur Herstellung von neuen 1-Crotonylcyclohex-2-enen
AT329531B (de) Verfahren zur herstellung von neuen hydroxycitronensaure-gamma-lactonderivaten
CH535253A (de) Verfahren zur Herstellung von substituierten Benzthiazolen
AT315201B (de) Verfahren zur Herstellung von neuen α-Alkoxy-ω-siloxanolen
AT320641B (de) Verfahren zur Herstellung von Oxazolinen
AT315829B (de) Verfahren zur Herstellung von 4-Halogenmethylcumarinen
AT309679B (de) Verfahren zur Herstellung von 6-Desoxytetracyclinen
AT319953B (de) Verfahren zur Herstellung von neuen substituierten Isazolopyrimidinen
AT324553B (de) Verfahren zur herstellung von 3-alkylthiomethylcephalosporinen
AT315196B (de) Verfahren zur Herstellung von neuen 6-Hydroxy-dihydro-uracilen
AT316560B (de) Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen
AT321309B (de) Verfahren zur Herstellung von neuen substituierten Isoxazolopyrimidinen
DD101403A5 (de) Verfahren zur herstellung von phenylimidazolidinonen
AT326816B (de) Verfahren zur herstellung von 3-carbamoyloxymethylcephalosporinverbindungen
AT327910B (de) Verfahren zur herstellung von 5-acyl-iminostilben-derivaten
AT310771B (de) Verfahren zur Herstellung von neuen Phosphinyl-alkylaminobenzophenonen
AT318823B (de) Verfahren zur Herstellung von 16-Carboxy-17-methoxy-eburnan
AT321258B (de) Verfahren zur Herstellung von Azinen
CH543571A (de) Verfahren zur Herstellung von 3,10-Dichlorchinacridon
AT315191B (de) Verfahren zur Herstellung von Arylsulfonylharnstoffen
CH528533A (de) Verfahren zur Herstellung von Thiazylharnstoffen
AT316512B (de) Verfahren zur Herstellung von Azinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee